Filing Details

Accession Number:
0001209191-10-018791
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-25 13:00:00
Reporting Period:
2010-02-25
Filing Date:
2010-03-25
Accepted Time:
2010-03-25 21:11:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006281 Protalix Biotherapeutics Inc. PLX Biological Products, (No Disgnostic Substances) (2836) 650643773
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1385118 Yoseph Shaaltiel C/O Protalix Biotherapeutics
2 Snunit Street Science Park, Pob 455
Carmiel L3 20100
Executive Vp, R&D Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-23 127,300 $7.02 1,136,454 No 4 S Direct
Common Stock Disposition 2010-03-24 202,700 $7.08 933,754 No 4 S Direct
Common Stock Disposition 2010-03-25 50,000 $7.00 883,754 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.